Guru Ownership Trend
Guru Analysis for ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (ACAD), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $128.08 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $12.69 M net outflow during the quarter.
Recent activity highlights Joel Greenblatt who increased their stake by 118.9%. Conversely, Steven Cohen reduced exposure by 23.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for ACADIA Pharmaceuticals Inc. (ACAD)
Major holders include Steven Cohen ($57.38 M), Renaissance Technologies (RenTech) ($38.38 M), Ken Fisher ($16.31 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 5.91 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $12.69 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ACAD. The total reported sell value was $19.5 M.
Yes, 0 managers opened new positions in ACAD, and 5 increased their existing holdings. The total reported buy value was $6.81 M.
